Press Release Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) Mineralys Therapeutics, Inc. · Jul 27
Press Release Gibson Energy Reports Second Quarter 2026 Results, Highlighted by Record Infrastructure Adjusted EBITDA and Strategic Growth Execution Gibson Energy Inc. · Jul 27
Press Release Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026 Nyxoah · Jul 27
Press Release Cerence to Announce Fiscal Third Quarter Results on August 6, 2026 Cerence Operating Company · Jul 27
Press Release ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer’s Disease ProMIS Neurosciences Inc. · Jul 27
Press Release Denali Therapeutics to Report Second Quarter 2026 Financial Results and Business Highlights on August 6, 2026 Denali Therapeutics Inc. · Jul 27
Press Release Scribe Therapeutics Announces Closing of Initial Public Offering, Full Exercise of Underwriters’ Option to Purchase Additional Shares, and Closing of the Concurrent Private Placement Scribe Therapeutics Inc. · Jul 27
Press Release Quantum-Si to Report Second Quarter 2026 Financial Results on August 13, 2026 Quantum-Si Incorporated · Jul 27
Press Release Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) Definitive Healthcare Corp. · Jul 27
Press Release Stuart Piltch Scholarship for Entrepreneurs Announces 2026 Application Cycle Stuart Piltch Scholarship · Jul 27
Press Release Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 Bionano Genomics · Jul 27
Press Release Oxford Square Capital Corp. Schedules Second Quarter 2026 Earnings Release and Conference Call for July 31, 2026 Oxford Square Capital Corp. · Jul 27